Global Humanoid Robots in Healthcare Market: 2024-2031
Report Overview The Global Humanoid Robots in Healthcare Market reached US$ 586.50 million in 2023 and is expected to reach US$ 6,307.45 million by 2031, growing at a CAGR of 34.5% during the for... もっと見る
SummaryReport OverviewThe Global Humanoid Robots in Healthcare Market reached US$ 586.50 million in 2023 and is expected to reach US$ 6,307.45 million by 2031, growing at a CAGR of 34.5% during the forecast period 2024-2031. Humanoid robots are artificial human-like machines built to mimic human-like activities and interactions. These are the most advanced forms of robots in the current world, finding their applications in manufacturing, warehousing & logistics, construction, hospitality & entertainment, healthcare, and general services. These advanced robots are currently utilized in the healthcare industry as companions in elderly care, for vital parameter recording and monitoring in hospitalized and home-based patients, and for assistance in general activities in the hospital. Market Dynamics: Drivers Rising investments in robotics In the current world, humanoid robots are the most advanced robots that are gaining huge popularity due to their ability to function and think like humans. The humanoid robots have already been deployed in various industries such as manufacturing, warehousing & logistics, hospitality, and entertainment. In the healthcare industry, these humanoid robots are still finding their applications, and only a limited number of companies have commercialized their robots. However, healthcare is the most promising sector for the future of humanoid robots, and the investments and funding are rising from the manufacturers and governments to develop and deploy them. These investments and funding are primary contributing factors to the market growth in the forecast period. For instance, in November 2023, a new Humanoid Robot Innovation Center was established in Beijing with the support of the Beijing government. Within a year of its establishment, the center has produced a new humanoid robot called Tien Kung. The general manager of Humanoid Robot Innovation Center, Mr. Rick Xiong has stated that humanoid robotics will be applied on a larger scale at home in the next three to five years. In addition, Sanctuary AI, an innovation-driven humanoid robot development company has raised US$ 140 million in funding from various investors till July 2024. The company received a US$ 30 million strategic innovation fund from the Canadian government earlier in 2022. Sanctuary AI aims to utilize these funds to accelerate its innovation in AI (artificial intelligence) and humanoid robotics. There are several companies which are at the innovation stage and are hugely receiving funding from government and private sectors. This funding will be utilized by them for the development of advanced humanoid robots, which may also expand their footprint in the healthcare sector. Restraints The market for humanoid robots in healthcare is restrained by several factors such as the limited availability of humanoid robots, limitations of humanoid robot applications, high cost, etc. At present the humanoid robots majorly find their application as a companion for elderly care, collecting patient details and vital parameters, and assisting in general hospital activities. Moreover, resistance by the elderly due to technological ambiguity may also restrain their utilization of their care services. Market Segment Analysis The global humanoid robots in healthcare market is segmented based on movement type, application, end users, and region. Elderly care in the application segment accounted for approximately 54.3% of the global humanoid robots market share Humanoid robots are currently used in the healthcare industry mainly for elderly care. They find their application in assisting them in day-to-day activities, providing companionship, helping them to communicate, measuring their vital signs, scheduling appointments with doctors, etc. These robots are highly intelligent and can understand human emotions, and expressions and respond like a human. They actively engage seniors in the home, care facilities, and hospitals through physical assistance, guiding them in exercises, recognizing their emotions and creating a cheerful environment, providing companionship in improving their cognitive ability, etc. The popular humanoid robot “Pepper” developed by SoftBank Robotics Group, and “PALRO” by FUJISOFT Inc. majorly find their application in providing elderly care. However, these robots are not just limited to elderly care applications, they can also be customized and trained for other applications in the healthcare industry. Similarly, the other robots like Prombot, Moxi, aeo, and Abi are not limited to hospital assistance, and vital parameter monitoring, they can also be trained for other healthcare applications. Market Geographical Analysis Asia-Pacific in global humanoid robots in healthcare market is expected to grow with the highest CAGR of 23.7% in the forecast period Asia-Pacific region is experiencing significant growth in the humanoid robots in the healthcare market due to higher research and development activities across industries, and research institutes especially in China and Japan. These countries are well known for their investments in industrial automation and currently have the technology to develop and deploy humanoid robots in the healthcare industry for various applications. At present the market leaders in humanoid robots dedicated to healthcare, arise from Japan and China. Pepper, which is the most famous humanoid robot was developed by a Japanese company SoftBank Robotics Group. Pepper is currently serving senior care facilities in Japan. Moreover, according to the International Trade Administration, Japan has 631 working robots for every 10,000 humans, and the U.S. has only 274 robots per 10,000 humans in 2021. By 2065, the workforce in Japan is expected to decline by 40%, which projects a higher demand for humanoid robots. China is also at the forefront of humanoid robot development. Several companies and research facilities are actively involved in the development. A Shangai-based company “Dataa Robotics” is actively involved in developing and deploying humanoid robots all across the world. The company has commercialized its robots since 2017. Moreover, one of the leading companies in the humanoid robotics market, i.e., UBTECH originated from China and has expanded business in the country and across the globe. There are several such companies in China, majorly located in Beijing, which are driving innovations in the robotics field. Market Segmentation By Movement Type Bipedal Wheeled By Application Vital Parameter Monitoring Appointment Scheduling Elderly Care Hospital Assistance Others By End Users Hospitals & Clinics Medical Universities Homecare Others By Region North America U.S. Canada Mexico Europe Germany U.K. France Spain Italy Rest of Europe South America Brazil Argentina Rest of South America Asia-Pacific China India Japan South Korea Rest of Asia-Pacific Middle East and Africa Market Competitive Landscape The major players in the humanoid robots in healthcare market include SoftBank Robotics America, Inc., Promobot, FUJISOFT Inc, Hanson Robotics Ltd., Diligent Robotics Inc., Aeolus, andromeda., Asimov Robotics., UBTECH ROBOTICS CORP LTD., and Dataa Robotics among others. Why Purchase the Report? To visualize the global humanoid robots in healthcare market segmentation based on movement type, application, end users, and region as well as understand key commercial assets and players. Identify commercial opportunities by analyzing trends and co-development Excel data sheet with numerous data points of humanoid robots in the healthcare market level with all segments. PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study. Product mapping available as excel consisting of key products of all the major players. The global humanoid robots in healthcare market report would provide approximately 62 tables, 54 figures, and 175 Pages. Target Audience 2024 Manufacturers/ Buyers Industry Investors/Investment Bankers Research Professionals Emerging Companies Table of Contents1. Methodology and Scope1.1. Research Methodology 1.2. Research Objective and Scope of the Report 2. Definition and Overview 3. Executive Summary 3.1. Snippet by Movement Type 3.2. Snippet by Application 3.3. Snippet by End Users 4. Dynamics 4.1. Impacting Factors 4.1.1. Drivers 4.1.1.1. Rising investments in robotics 4.1.1.2. Rising automation in the healthcare industry 4.1.2. Restraints 4.1.2.1. Limited applications of humanoid robots in healthcare 4.1.3. Opportunity 4.1.4. Impact Analysis 5. Industry Analysis 5.1. Porter's Five Force Analysis 5.2. Pricing Analysis 5.3. Regulatory Analysis 5.4. Unmet Needs 5.5. PESTEL Analysis 5.6. Patent Analysis 5.7. SWOT Analysis 6. By Movement Type 6.1. Introduction 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type 6.1.2. Market Attractiveness Index, By Movement Type 6.2. Bipedal* 6.2.1. Introduction 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 6.3. Wheeled 7. By Application 7.1. Introduction 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 7.1.2. Market Attractiveness Index, By Application 7.2. Vital Parameter Monitoring* 7.2.1. Introduction 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 7.3. Appointment Scheduling 7.4. Elderly Care 7.5. Hospital Assistance 7.6. Others 8. By End Users 8.1. Introduction 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users 8.1.2. Market Attractiveness Index, By End Users 8.2. Hospitals & Clinics* 8.2.1. Introduction 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 8.3. Medical Universities 8.4. Homecare 8.5. Others 9. By Region 9.1. Introduction 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region 9.1.2. Market Attractiveness Index, By Region 9.2. North America 9.2.1. Introduction 9.2.2. Key Region-Specific Dynamics 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 9.2.6.1. The U.S. 9.2.6.2. Canada 9.2.6.3. Mexico 9.3. Europe 9.3.1. Introduction 9.3.2. Key Region-Specific Dynamics 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users 9.3.5.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 9.3.5.2. Germany 9.3.5.3. UK 9.3.5.4. France 9.3.5.5. Italy 9.3.5.6. Spain 9.3.5.7. Rest of Europe 9.4. South America 9.4.1. Introduction 9.4.2. Key Region-Specific Dynamics 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users 9.4.5.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 9.4.5.2. Brazil 9.4.5.3. Argentina 9.4.5.4. Rest of South America 9.5. Asia-Pacific 9.5.1. Introduction 9.5.2. Key Region-Specific Dynamics 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users 9.5.5.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 9.5.5.2. China 9.5.5.3. India 9.5.5.4. Japan 9.5.5.5. South Korea 9.5.5.6. Rest of Asia-Pacific 9.6. Middle East and Africa 9.6.1. Introduction 9.6.2. Key Region-Specific Dynamics 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Movement Type 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users 10. Competitive Landscape 10.1. Competitive Scenario 10.2. Market Positioning/Share Analysis 10.3. Mergers and Acquisitions Analysis 11. Company Profiles 11.1. SoftBank Robotics America, Inc.* 11.1.1. Company Overview 11.1.2. Product Portfolio and Description 11.1.3. Financial Overview 11.1.4. Key Developments 11.2. Promobot 11.3. FUJISOFT Inc 11.4. Hanson Robotics Ltd. 11.5. Diligent Robotics Inc. 11.6. Aeolus 11.7. andromeda. 11.8. Asimov Robotics. 11.9. UBTECH ROBOTICS CORP LTD. 11.10. Dataa Robotics (*LIST NOT EXHAUSTIVE) 12. Appendix 12.1. About Us and Services 12.2. Contact Us
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
DataM Intelligence社の医療分野での最新刊レポート
本レポートと同じKEY WORD(healthcare)の最新刊レポート
よくあるご質問DataM Intelligence社はどのような調査会社ですか?DataM Intelligenceは世界および主要地域の広範な市場に関する調査レポートを出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |